Specialists in the Medical & Psychological Aspects of Transgender Health Care 

Carl W. Bushong, Ph.D., LMFT
Richard A. Martin, Jr., M.D., FACEP
Kimberly L. Westwood, CPE, CCE
et al.
  guidance & transition  
Transgender Care Health Information Archive 
 

  Topics & Issues

  Click item to view:
 Search
 TransGenderCare 


 Enter word or phrase:
 About
 TransGenderCare 
Our Web Site: TransGenderCare
Our Staff
Our History
Accuracy & Ethics Policy
Contact TransGenderCare
Privacy Policy
Terms of Use
home > Guidance & Transition > Resources > HBIGDA Standards of Care (01)

 HBIGDA STANDARDS OF CARE - 2001 (version 6) SECTIONS  
  Title Page
I. Introductory Concepts
II. Epidemiological Considerations
III. Diagnostic Nomenclature
IV. The Mental Health Professional
V. Assessment and Treatment of Children and Adolescents
VI. Psychotherapy with Adults
VII. Requirements for Hormone Therapy for Adults
 VIII. Effects of Hormone Therapy in Adults
 IX. The Real-life Experience
X. Surgery
XI. Breast Surgery
XII. Genital Surgery
XIII. Post-Transition Follow-up
   CLICK ON AN ITEM, ABOVE, TO GO TO THAT SECTION 

VII. Requirements for Hormone Therapy for Adults

Reasons for Hormone Therapy. Cross-sex hormonal treatments play an important role in the anatomical and psychological gender transition process for properly selected adults with gender identity disorders. Hormones are often medically necessary for successful living in the new gender. They improve the quality of life and limit psychiatric co-morbidity, which often accompanies lack of treatment. When physicians administer androgens to biologic females and estrogens, progesterone, and testosterone-blocking agents to biologic males, patients feel and appear more like members of their preferred gender.

Eligibility Criteria. The administration of hormones is not to be lightly undertaken because of their medical and social risks. Three criteria exist.

  1. Age 18 years;
  2. Demonstrable knowledge of what hormones medically can and cannot do and their social benefits and risks;
  3. Either:
    a. A documented real life experience of at least three months prior to the administration of hormones; or
    b. A period of psychotherapy of a duration specified by the mental health professional after the initial evaluation (usually a minimum of three months).

In selected circumstances, it can be acceptable to provide hormones to patients who have not fulfilled criterion 3 – for example, to facilitate the provision of monitored therapy using hormones of known quality, as an alternative to black-market or unsupervised hormone use.

Readiness Criteria. Three criteria exist:

  1. The patient has had further consolidation of gender identity during the real-life experience or psychotherapy;
  2. The patient has made some progress in mastering other identified problems leading to improving or continuing stable mental health (this implies satisfactory control of problems such as sociopathy, substance abuse, psychosis and suicidality;
  3. The patient is likely to take hormones in a responsible manner.

Can Hormones Be Given To Those Who Do Not Want Surgery or a Real-life Experience? Yes, but after diagnosis and psychotherapy with a qualified mental health professional following minimal standards listed above. Hormone therapy can provide significant comfort to gender patients who do not wish to cross live or undergo surgery, or who are unable to do so. In some patients, hormone therapy alone may provide sufficient symptomatic relief to obviate the need for cross living or surgery.

Hormone Therapy and Medical Care for Incarcerated Persons. Persons who are receiving treatment for gender identity disorders should continue to receive appropriate treatment following these Standards of Care after incarceration. For example, those who are receiving psychotherapy and/or cross-sex hormonal treatments should be allowed to continue this medically necessary treatment to prevent or limit emotional lability, undesired regression of hormonally-induced physical effects and the sense of desperation that may lead to depression, anxiety and suicidality. Prisoners who are subject to rapid withdrawal of cross-sex hormones are particularly at risk for psychiatric symptoms and self-injurious behaviors. Medical monitoring of hormonal treatment as described in these Standards should also be provided. Housing for transgendered prisoners should take into account their transition status and their personal safety.

Some of the resources in this section contain differing viewpoints comprising a variety of authors, committees, and interest groups. Additionally, some of these materials are delivered in an advisory context, covering legal, ethical, medical and social issues. These materials do not necessarily represent the guidelines of TransGenderCare or the philosophies of our staff.


Information provided and accessed through TransGenderCare.com is presented in a summary form and should not be used as a substitute for a consultation or visit with a physician, psychologist, electrologist or other health care provider. (See Terms & Conditions.) 

Site Help
Privacy Policy
Comments & Feedback

This Site may also be accessed via www.tgcare.com

Transgender Care Health Information Archive
Copyright © 1994-2007 TransGenderCare. All rights reserved.
Interested in linking to TransGenderCare?